Shares surged as Palantir delivered second-quarter results that obliterated Wall Street estimates, raising the question every investor must answer: at what price does even extraordinary growth stop justifying the ticket?

• Revenue Nearly Doubled, and the Beat Was Enormous

Palantir posted earnings per share of $0.41 against a consensus of $0.28 — a 46% beat — extending its streak to nine consecutive quarters of topping estimates. Revenue climbed 93% year-over-year to $1.94 billion, powered by U.S. commercial demand that soared 149% to $764 million . The top-line beat came in roughly $123 million above consensus of ~$1.81 billion . That is not a rounding error — it signals that corporate appetite for AI-powered data software is accelerating, not plateauing.

• Guidance Jumped by Half a Billion Dollars in One Quarter

Palantir raised full-year 2026 revenue guidance to $8.15–$8.16 billion, representing 82% year-over-year growth . Just last quarter, the full-year outlook stood at $7.65–$7.66 billion — meaning management added roughly $500 million to the forecast in 90 days. U.S. commercial guidance rose to "in excess of" $3.42 billion, up from $3.22 billion prior . For shareholders, repeated guidance raises build credibility that growth is durable, not front-loaded.

• Profitability Is Now a Weapon, Not a Promise

GAAP operating income reached $912 million at a 47% margin, while adjusted operating income hit $1.19 billion at a 62% margin . Net income tripled to $1.07 billion from $329 million a year ago . Unlike many AI-adjacent companies burning cash to grow, Palantir is compounding profits alongside revenue — a rare pairing that justifies a premium, though perhaps not this premium.

• The Valuation Leaves Zero Room for a Stumble

At recent levels, Palantir trades at roughly 43 times projected 2026 sales, with a trailing price-to-earnings ratio near 93 times . The stock doesn't merely need Palantir to keep performing at Q2's level — it needs that performance to continue long enough for the price tag to gradually shrink relative to earnings rather than collapse . The consensus analyst target sits near $190, with a range of $80 to $255 . Meanwhile, insider selling remains notable: CEO Alex Karp sold nearly 400,000 shares in May . The execution is undeniable; the question is whether the stock already reflects several years of it.